Higher risk of severe drug-induced liver injury among hispanic hiv-infected patients after initiation of highly active antiretroviral therapy

Journal of the International Association of Physicians in AIDS Care

Volumn 10, Issue 3, 2011, Pages 183-186

  Lamar, Zanetta S ^a   Núnez, Marina ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

DILI; ethnicity; HAART; hepatotoxicity

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ATAZANAVIR; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; STAVUDINE;

ADULT; AGED; ARTICLE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FATTY LIVER; FEMALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER INJURY; MALE; NEGRO; PILOT STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS HEPATITIS; HIV INFECTIONS; TOXIC HEPATITIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DRUG-INDUCED LIVER INJURY; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 79957441375     PISSN: 15451097     EISSN: 15570886     Source Type: Journal    
DOI: 10.1177/1545109711401411     Document Type: Article

References (16)

1. Núñez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology. 2010 ; 52 (3). 1143-1155.
2. Ingiliz P., Valantin MA, Duvivier C., et al. Liver damage underlying unexplained transaminase elevation in Human Immunodeficiency Virus-1 mono-infected patients on antiretroviral therapy. Hepatology. 2009 ; 49 (2). 436-442.
3. Santos L., Molina EG, Jeffers L. Prevalence of nonalcoholic steatohepatitis among ethnic groups. Gastroenterology. 2001 ; 120 (5). A117.
4. Browning JD, Szczepaniak LS, Dobbins R., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004 ; 40 (6). 1387-1395. (Pubitemid 39657013)
5. Weston SR, Leyden W., Murphy R., et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology. 2005 ; 41 (2). 372-379. (Pubitemid 40165382)
6. Ghany MG, Strader DB, Thomas DL, Seeff LB American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009 ; 49 (4). 1335-1374.
7. AIDS Clinical Trials Group. Table of Grading Severity of Adult Adverse Experiences. Rockville: Division of AIDS, National Institute of Allergy and Infectious Diseases ;; 1996.
8. Sulkowski M., Thomas D., Chaisson R., Moore R. Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C or B virus infection. JAMA. 2000 ; 283 (4). 74-80. (Pubitemid 30038386)
9. Wit Fwnm, Weverling GJ, Weel J., Jurriaans S., Lange JMA. Incidence of and risk factors for severe hepatotoxicity assocated with antiretroviral combination therapy. J Infect Dis. 2002 ; 186 (1). 23-31.
10. Law WP, Dore GJ, Duncombe CJ, et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001. AIDS. 2003 ; 17 (15). 2191-2199. (Pubitemid 37338892)
11. Rector RS, Thyfault JP, Wei Y., Ibdah JA Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol. 2008 ; 14 (2). 185-192. (Pubitemid 351314297)
12. Barbaro G. Highly active antiretroviral therapy-associated metabolic syndrome: pathogenesis and cardiovascular risk. Am J Ther. 2006 ; 13 (3). 248-260. (Pubitemid 44026193)
13. Sulkowski MS, Mehta SH, Torbenson M., et al. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005 ; 19 (6). 585-592. (Pubitemid 40543981)
14. Lemoine M., Barbu V., Girard PM, et al. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients. AIDS. 2006 ; 20 (3). 387-395.
15. Akhtar MA, Mathieson K., Arey B., et al. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis. Eur J Gastroenterol Hepatol. 2008 ; 20 (12). 1194-1204.
16. Mohanty SR, Troy TN, Huo D., O'Brien BL, Jensen DM, Hart J. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol. 2009 ; 50 (4). 797-804.